Leap Therapeutics, Inc. (LPTX)

Leap Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	47.25	70.64	65.5	114.92	52.07
Cash & Short-Term Investments	47.25	70.64	65.5	114.92	52.07
Cash Growth	-33.12%	7.85%	-43.00%	120.69%	1238.24%
Other Receivables	0.7	0.77	2.1	1.19	0.07
Receivables	0.7	0.77	2.1	1.19	0.07
Prepaid Expenses	0.09	0.18	0.35	0.77	0.13
Total Current Assets	48.04	71.6	67.95	116.87	52.27
Property, Plant & Equipment	0.26	0.26	0.69	0.5	0.59
Long-Term Deferred Tax Assets	-	-	-	0.16	0.18
Long-Term Deferred Charges	-	-	0.58	-	0.35
Other Long-Term Assets	0.82	0.97	1.14	0.38	0.98
Total Assets	49.12	72.83	70.35	117.91	54.37
Accounts Payable	4.74	6.47	5.66	4.19	2.72
Accrued Expenses	8.54	5.96	5.15	5.37	2.75
Current Portion of Leases	0.27	0.26	0.42	0.43	0.41
Current Income Taxes Payable	0.53	-	-	-	-
Current Unearned Revenue	-	-	-	-	1.5
Total Current Liabilities	14.08	12.68	11.23	9.99	7.37
Long-Term Leases	-	-	0.26	0.04	0.14
Other Long-Term Liabilities	-	-	-	-	0.2
Total Liabilities	14.08	12.68	11.49	10.02	7.72
Common Stock	0.04	0.03	0.01	0.09	0.06
Additional Paid-In Capital	502.5	459.59	376.9	371.64	270.16
Retained Earnings	-467.37	-399.58	-318.17	-263.57	-222.99
Comprehensive Income & Other	-0.12	0.11	0.13	-0.27	-0.58
Total Common Equity	35.05	60.14	58.87	107.89	46.65
Shareholders' Equity	35.05	60.14	58.87	107.89	46.65
Total Liabilities & Equity	49.12	72.83	70.35	117.91	54.37
Total Debt	0.27	0.26	0.68	0.47	0.55
Net Cash (Debt)	46.98	70.38	64.82	114.45	51.52
Net Cash Growth	-33.25%	8.58%	-43.36%	122.14%	1698.22%
Net Cash Per Share	1.25	3.44	5.72	13.33	8.68
Filing Date Shares Outstanding	41.26	25.6	11.88	8.83	5.97
Total Common Shares Outstanding	38.33	25.57	9.9	8.83	5.97
Working Capital	33.96	58.91	56.73	106.89	44.9
Book Value Per Share	0.91	2.35	5.94	12.22	7.82
Tangible Book Value	35.05	60.14	58.87	107.89	46.65
Tangible Book Value Per Share	0.91	2.35	5.94	12.22	7.82
Machinery	0.16	0.16	0.16	0.16	0.16
Leasehold Improvements	0.07	0.07	0.07	0.07	0.07

Updated Mar 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q